NAD+ IV therapy is a medical treatment that involves administering NAD+ directly into the bloodstream through...
ARA-290 - 10ml/40mg
It has been shown that the erythropoietin variation known as ARA-290 may reduce the activity of inflammatory pathways by using paracrine signalling and the innate repair receptors. According to research, ARA-290 may help lower HbA1c levels, improve cholesterol, modify peripheral neuropathies and general neuropathic pain, promote wound regeneration, and alleviate general neuropathic pain. - Cardiovascular disorders - Diabetic macular edema - Diabetic neuropathies - Neuropathic pain - Small fiber neuropathy - Rheumatoid arthritis - Diabetic nephropathies - Non-alcoholic steatohepatitis - Inflammatory bowel diseases - Systemic lupus erythematosus - Wounds Total Spray: 82 (490 mcg per spray) FRESHLY PREPARED SOLUTION